Revvity Inc (RVTY)
124.82
+3.78
(+3.12%)
USD |
NYSE |
Nov 04, 16:00
124.76
-0.06
(-0.05%)
Pre-Market: 20:00
Revvity Market Cap: 15.39B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 15.39B |
| November 01, 2024 | 14.93B |
| October 31, 2024 | 14.63B |
| October 30, 2024 | 14.80B |
| October 29, 2024 | 14.52B |
| October 28, 2024 | 14.49B |
| October 25, 2024 | 14.35B |
| October 24, 2024 | 14.32B |
| October 23, 2024 | 14.62B |
| October 22, 2024 | 14.65B |
| October 21, 2024 | 14.71B |
| October 18, 2024 | 14.76B |
| October 17, 2024 | 14.68B |
| October 16, 2024 | 14.82B |
| October 15, 2024 | 15.34B |
| October 14, 2024 | 15.16B |
| October 11, 2024 | 14.99B |
| October 10, 2024 | 14.83B |
| October 09, 2024 | 14.99B |
| October 08, 2024 | 15.05B |
| October 07, 2024 | 15.11B |
| October 04, 2024 | 15.29B |
| October 03, 2024 | 15.31B |
| October 02, 2024 | 15.43B |
| October 01, 2024 | 15.35B |
| Date | Value |
|---|---|
| September 30, 2024 | 15.76B |
| September 27, 2024 | 15.55B |
| September 26, 2024 | 15.58B |
| September 25, 2024 | 15.06B |
| September 24, 2024 | 15.41B |
| September 23, 2024 | 15.06B |
| September 20, 2024 | 15.16B |
| September 19, 2024 | 15.60B |
| September 18, 2024 | 15.37B |
| September 17, 2024 | 15.13B |
| September 16, 2024 | 15.15B |
| September 13, 2024 | 15.05B |
| September 12, 2024 | 14.82B |
| September 11, 2024 | 14.92B |
| September 10, 2024 | 14.93B |
| September 09, 2024 | 14.65B |
| September 06, 2024 | 14.23B |
| September 05, 2024 | 14.45B |
| September 04, 2024 | 14.51B |
| September 03, 2024 | 14.77B |
| August 30, 2024 | 15.11B |
| August 29, 2024 | 15.07B |
| August 28, 2024 | 14.96B |
| August 27, 2024 | 15.10B |
| August 26, 2024 | 14.95B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
7.425B
Minimum
Mar 16 2020
25.37B
Maximum
Dec 31 2021
15.48B
Average
14.96B
Median
Market Cap Benchmarks
| Bionano Genomics Inc | 24.29M |
| Avantor Inc | 15.35B |
| Bruker Corp | 8.985B |
| Azenta Inc | 2.197B |
| Harvard Bioscience Inc | 102.92M |
Market Cap Related Metrics
| PE Ratio | 90.68 |
| PS Ratio | 5.698 |
| Price to Book Value | 1.956 |
| Price to Free Cash Flow | 40.30 |
| Price | 124.82 |
| Earnings Yield | 1.10% |
| Operating PE Ratio | 55.74 |
| Normalized PE Ratio | 68.72 |